Development of an innovative compression sleeve for breast cancer-related arm lymphoedema
| Reference number | |
| Coordinator | PRESSCISE AB |
| Funding from Vinnova | SEK 940 000 |
| Project duration | January 2019 - May 2020 |
| Status | Completed |
Purpose and goal
The aim of the project was to develop a new innovative compression arm sleeve for the treatment of breast cancer-related lymphedema, based on PressCise´s patented technology. To validate the product through a clinical study and verify its business opportunities. Thanks to the funding, a working prototype has been developed and the clinical verification has been carried out.
Expected results and effects
A working arm sleeve prototype has been developed and clinical verification has been performed. The clinical trial resulted, among other things, in further proposals for the development of the product for optimal patient compliance. Discussions with market participants have shown positive indications as there is interest in an innovative product of this kind with the opportunity to compete with today´s offerings., through a lower purchase price and higher patient compliance, while a guaranteed and accurate pressure can be maintained over time even after severe edema reduction.
Planned approach and implementation
The product development was done in collaboration with a manufacturer of medical compression products. During the collaboration, continuous reconciliations and visits to the factory for practical execution of prototypes were carried out. The clinical trial was conducted at Sahlgrenska Physiotherapy under the supervision of the principal investigator. Patient recruitment was according to schedule and the study could be performed without much delay. Work on the article based on the study has begun but has not yet been completed.